Ridgeback Biotherapeutics LP
Miami, FL
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 3480 Main Hwy #402, Miami, FL 33133, USA
- Website
- ridgebackbio.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$455,905 |
| FY2025 | -$428,800 |
Contract awards
Quick answers
Is Ridgeback Biotherapeutics LP registered in SAM.gov?
Yes. Ridgeback Biotherapeutics LP's SAM.gov registration is active through March 2, 2027.
What is Ridgeback Biotherapeutics LP's CAGE code?
Ridgeback Biotherapeutics LP's CAGE code is 8B1C9, and its Unique Entity ID (UEI) is J486UJLMAKB5.
What is Ridgeback Biotherapeutics LP's most recent federal award?
Ridgeback Biotherapeutics LP's most recent federal contract award is CMC efforts for MAB114 for the development and treatment of ebola (75A50120C00009), from Office of the Assistant Secretary for Preparedness and Response, on March 19, 2020.
On GovTribe
See Ridgeback Biotherapeutics LP's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors